A detailed history of Blue Water Life Science Advisors, LP transactions in Personalis, Inc. stock. As of the latest transaction made, Blue Water Life Science Advisors, LP holds 1,132,900 shares of PSNL stock, worth $5.35 Million. This represents 5.96% of its overall portfolio holdings.

Number of Shares
1,132,900
Previous 1,000,000 13.29%
Holding current value
$5.35 Million
Previous $5.38 Million 21.71%
% of portfolio
5.96%
Previous 4.73%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025

BUY
$3.38 - $6.26 $449,202 - $831,954
132,900 Added 13.29%
1,132,900 $6.55 Million
Q3 2024

Nov 14, 2024

BUY
$1.19 - $6.34 $1.19 Million - $6.34 Million
1,000,000 New
1,000,000 $5.38 Million

Others Institutions Holding PSNL

About Personalis, Inc.


  • Ticker PSNL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 45,918,400
  • Market Cap $217M
  • Description
  • Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies and large-scale genetic research programs. It offers NeXT Platform, which provides data analysis for tumor and its immune microenvironment, from a single limited tissue or pla...
More about PSNL
Track This Portfolio

Track Blue Water Life Science Advisors, LP Portfolio

Follow Blue Water Life Science Advisors, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Blue Water Life Science Advisors, LP, based on Form 13F filings with the SEC.

News

Stay updated on Blue Water Life Science Advisors, LP with notifications on news.